A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia
Nadolol is a long-acting non-selective β–adrenergic antagonist that helps treat angina and hypertension. The current study aimed to develop and validate the physiologically based pharmacokinetic model (PBPK) of nadolol in healthy adults, renal-compromised, and pediatric populations. A comprehensive...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2024-02-01
|
| Серія: | Pharmaceuticals |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1424-8247/17/2/265 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|